Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Evaluation of low-intensity treatment strategies and outcomes in patients with accelerated Phase and blast Phase myeloproliferative neoplasms: A hero consortium study

Jenna Ciervo, Anthony Perissinotti, Adam Dipippo, Kayleigh Marx, Lydia Benitez, Caitlin Rausch, Kaitlyn Buhlinger, Benyam Muluneh, Hailey Hirata, Jeffrey Baron, Emma Uchida, Ashley Soule, Shawn Griffin, Benjamin Lee, Mimi Lo, Thu Doan, Janine Martino, Ila Saunders, Bernard Marini

Blood (2025) 146 (Supplement 1): 3818.

https://doi.org/10.1182/blood-2025-3818

Published: 2025

Journal Articles

Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Response to Intensive Induction Chemotherapy, Suggesting Futility of Mid-Cycle Bone Marrow Biopsy and Caution When Considering Re-Induction

Meira Yisraeli Salman, Alexander R. Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Yannis K. Valtis, Leora Boussi, Theresa Spivey, Wenbin Xiao, Christopher Famulare, Jenna Ciervo, Jacob M. Rowe, Martin S. Tallman, Eytan M. Stein

Blood (2024) 144 (Supplement 1): 2847.

https://doi.org/10.1182/blood-2024-193242

Published: 2024

Journal Articles

Outpatient Vs Inpatient Hidac Consolidation for AML: The MSKCC Experience

Leora Boussi, Hannah Burton, Andriy Derkach, David Nemirovsky, Jenna Ciervo, Martin S. Tallman, Eytan M. Stein, Sheng Cai

Blood (2024) 144 (Supplement 1): 445.

https://doi.org/10.1182/blood-2024-204449

Published: 2024

Journal Articles

Multicenter Retrospective Evaluation of Treatment of High-Risk Acute Promyelocytic Leukemia (APL): Results from the Hematology Research Outcomes (HERO) Consortium

Lydia Benitez, Kayleigh R. Marx, Kaitlyn M. Buhlinger, Stephen M. Clark, Justin H. Reid, Caitlin R Rausch, Katie S Gatwood, Sarah E. Stump, Richa Shah, Jenna Ciervo, Jeffrey Baron, Bernard Lawrence Marini, Anthony J. Perissinotti, Madeline Waldron, Benyam Muluneh

Blood (2023) 142 (Supplement 1): 4267.

https://doi.org/10.1182/blood-2023-189637

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Evaluation of low-intensity treatment strategies and outcomes in patients with accelerated Phase and blast Phase myeloproliferative neoplasms: A hero consortium study

Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Response to Intensive Induction Chemotherapy, Suggesting Futility of Mid-Cycle Bone Marrow Biopsy and Caution When Considering Re-Induction

Outpatient Vs Inpatient Hidac Consolidation for AML: The MSKCC Experience

Multicenter Retrospective Evaluation of Treatment of High-Risk Acute Promyelocytic Leukemia (APL): Results from the Hematology Research Outcomes (HERO) Consortium

Email alerts

ASH Publications

American Society of Hematology

Update search

Evaluation of low-intensity treatment strategies and outcomes in patients with accelerated Phase and blast Phase myeloproliferative neoplasms: A hero consortium study

Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Response to Intensive Induction Chemotherapy, Suggesting Futility of Mid-Cycle Bone Marrow Biopsy and Caution When Considering Re-Induction

Outpatient Vs Inpatient Hidac Consolidation for AML: The MSKCC Experience

Multicenter Retrospective Evaluation of Treatment of High-Risk Acute Promyelocytic Leukemia (APL): Results from the Hematology Research Outcomes (HERO) Consortium

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only